Hypercalcemia Differential Diagnoses

1. Walker MD, Shane E. Hypercalcemia: A Review. JAMA. 2022 Oct 25. 328 (16):1624-1636. [QxMD MEDLINE Link].

2. Sadiq NM, Naganathan S, Badireddy M. Hypercalcemia. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].

3. Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: Differential diagnosis and treatment. CA Cancer J Clin. 2018 Sep 21. [QxMD MEDLINE Link]. [Full Text].

4. Hoenderop JG, Nilius B, Bindels RJ. Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Annu Rev Physiol. 2002. 64:529-49. [QxMD MEDLINE Link].

5. McKay CP, Portale A. Emerging topics in pediatric bone and mineral disorders 2008. Semin Nephrol. 2009 Jul. 29(4):370-8. [QxMD MEDLINE Link].

6. Guarnieri V, Canaff L, Yun FH, et al. Calcium-Sensing Receptor (CASR) Mutations in Hypercalcemic States: Studies from a Single Endocrine Clinic Over Three Years. J Clin Endocrinol Metab. 2010 Feb 17. [QxMD MEDLINE Link].

7. Nissen PH, Christensen SE, Wallace A, et al. Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disorders. Clin Endocrinol (Oxf). 2009 Nov 11. [QxMD MEDLINE Link].

8. Luna-Cabrera F, Justicia-Rull EA, Caricol-Pérez MP, et al. Incidence of hypercalcemia, hypercalciuria and related factors in patients treated with recombinant human parathyroid hormone (1-84). Minerva Med. 2012 Apr. 103(2):103-10. [QxMD MEDLINE Link].

9. Nanmoku K, Shinzato T, Kubo T, Shimizu T, Yagisawa T. Prevalence and predictors of early hypercalcemia after kidney transplantation: a nested case-control study within a cohort of 100 patients. Clin Exp Nephrol. 2018 Aug 18. [QxMD MEDLINE Link].

10. Vanstone MB, Oberfield SE, Shader L, Ardeshirpour L, Carpenter TO. Hypercalcemia in Children Receiving Pharmacologic Doses of Vitamin D. Pediatrics. 2012 Mar 12. [QxMD MEDLINE Link].

11. Haridas K, Holick MF, Burmeister LA. Hypercalcemia, nephrolithiasis, and hypervitaminosis D precipitated by supplementation in a susceptible individual. Nutrition. 2020 Jun. 74:110754. [QxMD MEDLINE Link].

12. Griebeler ML, Kearns AE, Ryu E, Thapa P, Hathcock MA, Melton LJ 3rd, et al. Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades. J Clin Endocrinol Metab. 2016 Mar. 101 (3):1166-73. [QxMD MEDLINE Link].

13. Vargas-Poussou R, Mansour-Hendili L, Baron S, et al. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences. J Clin Endocrinol Metab. 2016 May. 101 (5):2185-95. [QxMD MEDLINE Link].

14. John SM, Sagar S, Aparna JK, Joy S, Mishra AK. Risk factors for hypercalcemia in patients with tuberculosis. Int J Mycobacteriol. 2020 Jan-Mar. 9 (1):7-11. [QxMD MEDLINE Link]. [Full Text].

15. Gastanaga VM, Schwartzberg LS, Jain RK, Pirolli M, Quach D, Quigley JM, et al. Prevalence of hypercalcemia among cancer patients in the United States. Cancer Med. 2016 Jun 5. [QxMD MEDLINE Link].

16. Royer AM, Maclellan RA, Daniel Stanley J, Willingham TB, Heath Giles W. Hypercalcemia in the emergency department: a missed opportunity. Am Surg. 2014 Aug. 80(8):732-5. [QxMD MEDLINE Link].

17. Cafforio P, Savonarola A, Stucci S, De Matteo M, Tucci M, Brunetti AE, et al. PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. J Bone Miner Res. 2014 Jan. 29(1):55-66. [QxMD MEDLINE Link].

18. Goldner W. Cancer-Related Hypercalcemia. J Oncol Pract. 2016 May. 12 (5):426-32. [QxMD MEDLINE Link].

19. Vallet N, Ertault M, Delaye JB, Chalopin T, Villate A, Drieu La Rochelle L, et al. Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported cases. Ann Hematol. 2020 Feb. 99 (2):229-239. [QxMD MEDLINE Link].

20. Alsirafy SA, Sroor MY, Al-Shahri MZ. Hypercalcemia in advanced head and neck squamous cell carcinoma: prevalence and potential impact on palliative care. J Support Oncol. 2009 Sep-Oct. 7(5):154-7. [QxMD MEDLINE Link].

21. Durant E, Singh A. ST elevation due to hypercalcemia. Am J Emerg Med. 2017 Jul. 35 (7):1033.e3-1033.e6. [QxMD MEDLINE Link].

22. Sonoda K, Watanabe H, Hisamatsu T, Ashihara T, Ohno S, Hayashi H, et al. High Frequency of Early Repolarization and Brugada-Type Electrocardiograms in Hypercalcemia. Ann Noninvasive Electrocardiol. 2016 Jan. 21 (1):30-40. [QxMD MEDLINE Link].

23. Schutt RC, Bibawy J, Elnemr M, Lehnert AL, Putney D, Thomas AS, et al. Case report: Severe hypercalcemia mimicking ST-segment elevation myocardial infarction. Methodist Debakey Cardiovasc J. 2014 Jul-Sep. 10 (3):193-7. [QxMD MEDLINE Link]. [Full Text].

24. Makras P, Papapoulos SE. Medical treatment of hypercalcaemia. Hormones (Athens). 2009 Apr-Jun. 8(2):83-95. [QxMD MEDLINE Link]. [Full Text].

25. Turner JJO. Hypercalcaemia - presentation and management. Clin Med (Lond). 2017 Jun. 17 (3):270-273. [QxMD MEDLINE Link].

26. Brooks M. FDA Approves New Indication for Denosumab (Xgeva). Medscape Medical News. Available at http://www.medscape.com/viewarticle/836252. Accessed: December 13, 2014.

27. Hu MI, Glezerman IG, Leboulleux S, Insogna K, Gucalp R, Misiorowski W, et al. Denosumab for treatment of hypercalcemia of malignancy. J Clin Endocrinol Metab. 2014 Sep. 99(9):3144-52. [QxMD MEDLINE Link]. [Full Text].

28. Bergenfelz AO, Jansson SK, Wallin GK, et al. Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients. Langenbecks Arch Surg. 2009 Jul 18. [QxMD MEDLINE Link].

29. Low TH, Clark J, Gao K, et al. Outcome of parathyroidectomy for patients with renal disease and hyperparathyroidism: predictors for recurrent hyperparathyroidism. ANZ J Surg. 2009 May. 79(5):378-82. [QxMD MEDLINE Link].

30. [Guideline] Dickens LT, Derman B, Alexander JT. Endocrine Society Hypercalcemia of Malignancy Guidelines. JAMA Oncol. 2023 Jan 13. [QxMD MEDLINE Link]. [Full Text].

Mahendra Agraharkar, MD, MBBS, FACP, FASN Clinical Associate Professor of Medicine, Baylor College of Medicine; President and CEO, Space City Associates of Nephrology

Mahendra Agraharkar, MD, MBBS, FACP, FASN is a member of the following medical societies: American College of Physicians, American Society of Nephrology, National Kidney Foundation

Disclosure: Nothing to disclose.

O David Dellinger, III, MD Assistant Professor, Departments of Family Medicine and Internal Medicine, University of Alabama School of Medicine at Birmingham

O David Dellinger, III, MD is a member of the following medical societies: American Academy of Hospice and Palliative Medicine, American College of Physicians-American Society of Internal Medicine, American Geriatrics Society, AMDA - The Society for Post-Acute and Long-Term Care Medicine, American Society of Addiction Medicine

Disclosure: Nothing to disclose.

Arun Kumar Gangakhedkar, MD, FRACP Consultant in General Pediatrics, Starship Children's Hospital/Waitakere Hospital, New Zealand

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Christie P Thomas, MBBS, FRCP, FASN, FAHA Professor, Department of Internal Medicine, Division of Nephrology, Departments of Pediatrics and Obstetrics and Gynecology, Medical Director, Kidney and Kidney/Pancreas Transplant Program, University of Iowa Hospitals and Clinics

Christie P Thomas, MBBS, FRCP, FASN, FAHA is a member of the following medical societies: American College of Physicians, American Heart Association, American Society of Nephrology, Royal College of Physicians

Disclosure: Nothing to disclose.

Vecihi Batuman, MD, FASN Professor of Medicine, Section of Nephrology-Hypertension, Deming Department of Medicine, Tulane University School of Medicine

Vecihi Batuman, MD, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article